The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...
In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...
InvestorsHub on MSN
Aldeyra receives FDA rejection for dry eye treatment reproxalap
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) said it has received a Complete Response Letter from the U.S. Food and Drug Administration rejecting its New Drug Application for reproxalap, a proposed ...
Investor interest in IPL cricket teams is escalating, with David Blitzer and Avram Glazer leading the bids. Evaluations involve teams like Royal Challengers Bengaluru and Rajasthan Royals. Global ...
From the start of my career, I have approached dry eye disease (DED) with an interventional, science-based strategy. For too long, DED was not treated as a true disease, with little interest or ...
HOUSTON, TX, UNITED STATES, February 12, 2026 /EINPresswire.com/ — From classrooms and conference rooms to living rooms and daily commutes, screens now dominate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results